Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Resistance, Multiple”

310 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 310 results

Testing effectiveness (Phase 2)Ended earlyNCT05971602
What this trial is testing

Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
Gates Medical Research Institute 93
Testing effectiveness (Phase 2)Study completedNCT00001493
What this trial is testing

Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 42
Not applicableStudy completedNCT04038814
What this trial is testing

The Effectiveness of the Modified Bundle in the Prevention of VAP.

Who this might be right for
VAP - Ventilator Associated Pneumonia
Andrzej Frycz Modrzewski Krakow University 386
Not applicableStudy completedNCT02605499
What this trial is testing

Ultra Violet-C Light Evaluation as an Adjunct to Removing Multi-Drug Resistant Organisms (UVCLEAR-MDRO)

Who this might be right for
Healthcare Associated InfectionMultidrug Resistant Organisms
Johns Hopkins University 83
Very early researchLooking for participantsNCT06792799
What this trial is testing

Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease

Who this might be right for
Autoimmune DiseasesSystemic Lupus ErthematosusMulti-Drug Resistant Nephrotic Syndrome+1 more
The Children's Hospital of Zhejiang University School of Medicine 36
Not applicableUnknownNCT00102934
What this trial is testing

Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Post-approval studies (Phase 4)UnknownNCT02297477
What this trial is testing

The ASAP Study - Therapeutic Efficacy of Atovaquone-proguanil vs. Artesunate-atovaquone-proguanil in Cambodia

Who this might be right for
Malaria
Armed Forces Research Institute of Medical Sciences, Thailand 205
Early research (Phase 1)Study completedNCT05780801
What this trial is testing

Sentinel Cohort REACT

Who this might be right for
Multi-Drug Resistant Organism
Emory University 10
Not applicableStudy completedNCT04383106
What this trial is testing

Bowel Colonization With Multi-drug Resistant Bacterial Species in Hospitalized Patients With acute-on Chronic Liver Failure (ACLF), and Its Relationship With Extra-intestinal Infectious Events and Short-term Outcomes.

Who this might be right for
Acute-On-Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 150
Testing effectiveness (Phase 2)UnknownNCT03164447
What this trial is testing

UB-421 Combine With Optimized Background Therapy Regimen in Multi-Drug Resistant HIV-1 Infection Patients

Who this might be right for
HIV-1 Infection
United BioPharma 10
Large-scale testing (Phase 3)Study completedNCT05349838
What this trial is testing

Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTI Mutation K103N

Who this might be right for
HIV-1-infection
NEAT ID Foundation 140
Early research (Phase 1)Study completedNCT03910673
What this trial is testing

Intravenous Fosfomycin Pharmacokinetics Study

Who this might be right for
Bacterial InfectionMultiple-drug ResistancePathogen Resistance
National Institute of Allergy and Infectious Diseases (NIAID) 39
Not applicableUnknownNCT05300776
What this trial is testing

M-ROSE Combined With mNGS in Severe Hospital-acquired Pneumonia

Who this might be right for
Pneumonia
Chinese PLA General Hospital 166
Not applicableNot Yet RecruitingNCT06674291
What this trial is testing

Registry on the Effectiveness and Safety of the 9-month MDR-END Treatment Regimen in Korean Patients with FQ-sensitive MDR-TB (MDR-END Registry)

Who this might be right for
Tuberculosis, Multidrug-Resistant
Korea Otsuka Pharmaceutical Co., Ltd. 222
Not applicableNot Yet RecruitingNCT07487116
What this trial is testing

Phenotypic and Genotypic Detection of Colistin Resistance

Who this might be right for
Patients With Multi Drug Resistant Gram-negative BacteriaColistin Resistance in Bacteria
Assiut University 90
Not applicableStudy completedNCT06760143
What this trial is testing

Antibiotic Prophylaxis in Lung-Transplant Recipients

Who this might be right for
Lung-transplant RecipientsAntibiotic Prophylaxis
IRCCS Azienda Ospedaliero-Universitaria di Bologna 90
Early research (Phase 1)Study completedNCT01856634
What this trial is testing

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Who this might be right for
Multidrug Resistant TuberculosisPediatric
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Testing effectiveness (Phase 2)Looking for participantsNCT04759001
What this trial is testing

FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae

Who this might be right for
Enterobacteriaceae InfectionsMulti-antibiotic Resistance
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 52
Not applicableLooking for participantsNCT06738771
What this trial is testing

Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

Who this might be right for
Pseudomonas InfectionsPseudomonas AeruginosaPrognosis+3 more
Centre Hospitalier Régional d'Orléans 600
Not applicableStudy completedNCT02729532
What this trial is testing

Effect of Xpert MTB/RIF on Patient Outcomes

Who this might be right for
Tuberculosis
University of North Carolina, Chapel Hill 776
Load More Results